EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia

Nataliia Sergeevna Karpova, Olga Pavlovna Dmitrenko iD, Tatyana Sergeevna Budykina

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076744 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nataliia Sergeevna Karpova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Federal State Budgetary Institution "Research Institute of Pathology and Pathophysiology", St. Baltiyskaya, House 8, Moscow 125315, Russia. Hauptthemen laut MEDLINE: Pre-Eclampsia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences, Federal State Budgetary Institution “Research Institute of Pathology and Pathophysiology”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the main causes of maternal and neonatal morbidity and mortality is pre-eclampsia. It is characterized by a high sFlt1/PlGF ratio, according to prior research. Pregestational diseases in mothers may increase the risk of developing pre-eclampsia. Only a few studies have looked at the connection between maternal comorbidities before conception and the sFlt1/PlGF ratio. The most recent information regarding the association between maternal pregestational diseases and the ratio of sFlt1/PlGF is described in this review. The paper also examines current research suggesting that changes in pregnancy hormones and metabolites are related to a high sFlt1/PlGF ratio. Certain maternal disorders have been found to dramatically raise sFlt-1 and sFlt1/PlGF levels, according to an analysis of the literature. There is still debate about the data on the association between the sFlt1/PlGF ratio and maternal disorders such as HIV, acute coronary syndromes, cardiovascular function in the mother between 19 and 23 weeks of pregnancy, thyroid hormones, diabetes, and cancer. Additional research is needed to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPregnancyFemaleInfant, NewbornHumansVascular Endothelial Growth Factor Receptor-1Placenta Growth FactorRisk FactorsBiomarkers

Stichwörter der Autor:innen

COVID-19HELLPcardiovascular diseasechronic hypertensionmaternal comorbiditiespre-eclampsiapregnancysFlt1/PlGF ratiosoluble Fms-like tyrosine kinase-1

Substanzen

FLT1 protein, humanVascular Endothelial Growth Factor Receptor-1Placenta Growth FactorBiomarkers

Autor:innen und Institutionen

  • Federal State Budgetary Institution "Research Institute of Pathology and Pathophysiology", St. Baltiyskaya, House 8, Moscow 125315, Russia.
  • State Budgetary Health Institution of the Moscow Region "Moscow Regional Research Institute of Obstetrics and Gynecology", St. Pokrovka, d.22a, Moscow 101000, Russia.

ORCID-Profile: Olga Pavlovna Dmitrenko

Förderung

  • Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences
  • Federal State Budgetary Institution “Research Institute of Pathology and Pathophysiology”

Zitieren

APA

Karpova, N. S., Dmitrenko, O. P., & Budykina, T. S. (2023). Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076744

Vancouver

Karpova NS, Dmitrenko OP, Budykina TS. Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076744

BibTeX
@article{Karpova2023,
  author = {Karpova, Nataliia Sergeevna and Dmitrenko, Olga Pavlovna and Budykina, Tatyana Sergeevna},
  title = {Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076744}
}
Kostenlos starten →